Scarica l'app Stockscreener
59.76
0.18%
0.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché INSP Giù?
Forum
Previsione
Precedente Chiudi:
$59.65
Aprire:
$59.64
Volume 24 ore:
1.89M
Relative Volume:
1.18
Capitalizzazione di mercato:
$1.71B
Reddito:
$861.31M
Utile/perdita netta:
$53.12M
Rapporto P/E:
34.62
EPS:
1.7262
Flusso di cassa netto:
$85.01M
1 W Prestazione:
-9.04%
1M Prestazione:
-35.37%
6M Prestazione:
-31.59%
1 anno Prestazione:
-68.07%
Intervallo 1D:
$59.64
$63.50
Intervallo di 1 settimana:
$53.11
$71.16
Portata 52W:
$53.11
$197.75
Inspire Medical Systems Inc Stock (INSP) Company Profile
Nome
Inspire Medical Systems Inc
Settore
Industria
Telefono
763-957-5037
Indirizzo
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
59.76 | 1.70B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Downgrade | Truist | Buy → Hold |
| 2025-12-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Aggiornamento | Truist | Hold → Buy |
| 2025-11-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-22 | Downgrade | UBS | Buy → Neutral |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Downgrade | Truist | Buy → Hold |
| 2024-11-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-04-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2024-01-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-12-13 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-11-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-11-03 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-15 | Iniziato | Goldman | Buy |
| 2020-06-18 | Reiterato | Piper Sandler | Overweight |
| 2020-05-18 | Iniziato | Lake Street | Buy |
| 2020-04-28 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Iniziato | Piper Sandler | Overweight |
| 2020-01-28 | Iniziato | Oppenheimer | Underperform |
| 2020-01-27 | Iniziato | Oppenheimer | Underperform |
| 2019-11-06 | Aggiornamento | Berenberg | Sell → Hold |
| 2019-02-05 | Iniziato | Dougherty & Company | Buy |
| 2018-11-28 | Iniziato | Berenberg | Sell |
| 2018-10-29 | Iniziato | Leerink Partners | Outperform |
| 2018-05-29 | Iniziato | Guggenheim | Buy |
| 2018-05-29 | Iniziato | Stifel | Buy |
| 2018-05-29 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Inspire Medical Systems Inc Borsa (INSP) Ultime notizie
Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc.INSP - PR Newswire
Inspire Medical Systems, Inc. SEC 10-K Report - TradingView
INSP Downgraded to Peer Perform by Wolfe Research | INSP Stock N - GuruFocus
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
6.4 Million Medicare Recipients Face New Hurdles in Getting Care - AOL.com
Inspire Medical Systems (NYSE:INSP) Downgraded to Hold Rating by Robert W. Baird - MarketBeat
Inspire Medical Systems (NYSE:INSP) Lowered to "Hold" Rating by Wells Fargo & Company - MarketBeat
Wolfe Research downgrades Inspire Medical Systems stock rating to Peerperform - Investing.com Canada
Inspire Medical Systems stock hits 52-week low at $56.17 By Investing.com - Investing.com Canada
Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns - Investing.com Nigeria
Baird downgrades Inspire Medical stock to Neutral on reimbursement concerns - Investing.com Nigeria
What the FDA’s 2026 Update Means for Wearables - AOL.com
Jefferies Lowers Price Target for INSP, Keeps Hold Rating | INSP Stock News - GuruFocus
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $66.00 by Analysts at Jefferies Financial Group - MarketBeat
Analyst Shagun Singh Maintains Rating for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus
Stifel lowers Inspire Medical Systems stock price target on reimbursement issues - Investing.com Canada
Inspire Medical: Still A Long Way From A Good Night’s Sleep (NYSE:INSP) - Seeking Alpha
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz
Inspire Medical Systems Lowers FY2026 Revenue Guidance After CMS Coding Clarification, Oppenheimer Says - marketscreener.com
INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands - Yahoo Finance Singapore
Inspire Medical Systems (NYSE:INSP) Shares Gap Down on Analyst Downgrade - MarketBeat
Piper Sandler Lowers Price Target for INSP to $85, Maintains Ove - GuruFocus
Wells Fargo Downgrades INSP to Equal-Weight, Lowers Price Target - GuruFocus
INSP: Mizuho Lowers Price Target to $85, Maintains Outperform Ra - GuruFocus
Inspire Medical Systems stock hits 52-week low at $56.17 - Investing.com
INSP Q4 Deep Dive: Reimbursement Uncertainty Shapes Outlook Despite Strong Product Adoption - Finviz
This Inspire Medical Systems Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Truist Cuts Price Target on Inspire Medical Systems to $70 From $96, Keeps Hold Rating - marketscreener.com
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $70.00 by Analysts at Truist Financial - MarketBeat
Inspire Medical Systems (NYSE:INSP) Given New $85.00 Price Target at Piper Sandler - MarketBeat
Mizuho Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 earnings call transcript - MSN
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Inspire Medical Systems to $68 From $90, Keeps Sector Perform Rating - marketscreener.com
Baird Downgrades Inspire Medical Systems to Neutral From Outperform, Adjusts Price Target to $74 From $130 - marketscreener.com
Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns By Investing.com - Investing.com India
What 19 Analyst Ratings Have To Say About Inspire Medical Systems - Benzinga
Inspire Medical Stock Pre-Market (-8.7%) : Weak 2026 Revenue Guidance - Trefis
Baird Downgrades Inspire Medical Systems (INSP) and Lowers Price Target | INSP Stock News - GuruFocus
Wells Fargo downgrades Inspire Medical Systems stock rating on reimbursement concerns - Investing.com India
How Investors May Respond To Inspire Medical Systems (INSP) Surging 2025 Profit Versus Cautious Expectations - Sahm
Inspire Medical Systems Q4 2025 Earnings Call Transcript - MarketBeat
Inspire Medical Systems (INSP) Reports Strong Q4 Revenue Growth - GuruFocus
Inspire Medical Systems Q4 Earnings Call Highlights - MarketBeat
Inspire Medical (INSP) Q4 2025 Earnings Transcript - AOL.com
Inspire Medical Systems Q4 2025 slides: revenue hits $912M, projects slower growth - Investing.com India
Earnings call transcript: Inspire Medical Systems Q4 2025 Earnings Beat Forecasts - Investing.com Nigeria
Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook - MSN
Inspire Medical Systems (NYSE:INSP) Stock Plunges on Weak 2026 Outlook Despite Q4 Earnings Beat - ChartMill
Inspire Medical Systems earnings beat by $0.97, revenue topped estimates - Investing.com Canada
Inspire Medical Systems Inc Azioni (INSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):